The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines is a research paper published in PLoS Pathogens (2021). On theSindex it has a DataRank of 0.574. It has been cited 45 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.574
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Health
Grant: F31 Al143234
National Institute of Health
Grant: R01 Al093848
National Institute of Health
Grant: P01 Al112524
Cystic Fibrosis Foundation Therapeutics, Inc.
Grant: MCCOY17R2
NIAID NIH HHS
Grant: F31 AI143234
NIAID NIH HHS
Grant: R01 AI093848
NIAID NIH HHS
Grant: P01 AI112524
National Institutes of Health
Grant: 5P01AI112524-02
Live Attenuated RSV Vaccine with Optimized Safety and Immunogenicity
National Institutes of Health
Grant: 1F31AI143234-01A1
Altered structure and activity of the RSV attachment glycoprotein produced in primary human airway cells
National Institutes of Health
Grant: 5R01AI093848-02
Respiratory Syncytial Virus Targeting of the Human Airway Epithelium
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals